Comments

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF Stock Price, Quotes and Forecasts

THNRARCA
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$22.59
-0.07-0.30%
At close: -

Overview

NewsHoldingsDividendsShort Interest
Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Sector
Healthcare
Region
US
AUM
2.93M
Fund Score

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF Price, Quotes and Forecasts | ARCA:THNR | Benzinga

Explore Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for THNR.

Open$22.73
High$22.73
52 Wk High$28.19
AUM2.93M
Dividend-
Ex-Div Date-
Volume1.35K
Market Cap$297.56B
Mgmt Fee0.59%
P/E Ratio32.56
Prev. Close$22.66
Low$22.59
52 Wk Low$18.56
Shares Out130.00K
Yield-
Div. Freq-
Avg. Volume Daily2.63K
Beta0.59
Avg. Expense Ratio0.59%
P/B Ratio6.09

Recent News

Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase.
Pooja Rajkumari
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.
Piero Cingari
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and the concentrated risks associated with these investments.
Vandana Singh

FAQ

Q

How do I buy Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) stock?

A

You can purchase shares of Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) competitors?

A

There are no as such competitors for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.

Q

What is the forecast, or price target, for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) stock?

A

There is no analysis for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.

Q

What is the current price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR)?

A

The stock price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $22.68 last updated June 23, 2025 at 9:29 AM EDT.

Q

Does Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) pay a dividend?

A

A quarterly cash dividend of 0.22 per share of Class A Common Stock. The quarterly cash dividend was payable on December 31, 2024 to stockholders of record on December 30, 2024.

Q

When is Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) reporting earnings?

A

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.

Q

Is Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) going to split?

A

There is no upcoming split for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.

Open$22.73
High$22.73
52 Wk High$28.19
AUM2.93M
Dividend-
Ex-Div Date-
Volume1.35K
Market Cap$297.56B
Mgmt Fee0.59%
P/E Ratio32.56
Prev. Close$22.66
Low$22.59
52 Wk Low$18.56
Shares Out130.00K
Yield-
Div. Freq-
Avg. Volume Daily2.63K
Beta0.59
Avg. Expense Ratio0.59%
P/B Ratio6.09
About Amplify ETF Trust
Sector
N/A
Industry
N/A
ETF Details
SectorHealthcare
CategoryShort Term Safe
Investment StyleLarge Cap Blend
Fund InceptionMay 21, 2024
Managers
Dustin Lewellyn
Ernesto Tong
DefinitionFixed income fund portfolio contains a large percentage of securities with low duration and superior credit quality
Investment Policy
The Fund invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the Index. VettaFi LLC, a wholly-owned subsidiary of TMX Group Limited developed and maintains the Index (the Index Provider).
Top ETF Holdings
SymbolNameShare %
LLYEli Lilly & Co.13.9%
CONovo Nordisk A/S ADR13.9%
LNDeveloped Markets Astr...4.66%
AMGNAmgen Inc.4.60%
PFEPfizer, Inc.4.69%
JPChugai Pharmaceutical ...5.60%
SMRoche Holding Ag4.64%
MRKMerck & Co. Inc.4.77%
WSTWest Pharmaceutical Se...4.67%
TMOThermo Fisher Scientif...5.01%
SHInnovent Biologics Inc6.61%
TEVATeva Pharmaceutical In...5.18%
HIMSHims & Hers Health Inc6.67%

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved